These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2456793)

  • 1. [Vestibulo-protective properties of regulatory peptides].
    Drozd IuV; Iasnetsov VV; Shashkov VS
    Biull Eksp Biol Med; 1988 Jul; 106(7):50-2. PubMed ID: 2456793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Emetic and antiemetic properties of regulatory peptides].
    Iasnetsov VV; Drozd IuV; Shashkov VS
    Biull Eksp Biol Med; 1987 May; 103(5):586-8. PubMed ID: 2439138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of opioid peptides in the pathogenesis of vestibulo-autonomic disorders].
    Shashkov VS; Drozd IuV; Iasnetsov VV; Galkina EIu; Riumin IuI
    Kosm Biol Aviakosm Med; 1988; 22(1):37-40. PubMed ID: 2966258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of peptide-protein substances from the hydrobiontics in vestibulo-autonomic disorders in cats].
    Drozd IuV; Evstratov AV; Ivanov MP; Batrakov SG; Sakandelidze OG; Shashkov VS; Iasnetsov VV
    Biull Eksp Biol Med; 1990 Jan; 109(1):44-6. PubMed ID: 2334797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Protective action of peptides against motion sickness in animals].
    Iasnetsov VV; Drozd IuV; Shashkov VS; Bragin EO; Popkova EV
    Kosm Biol Aviakosm Med; 1988; 22(2):72-3. PubMed ID: 3379906
    [No Abstract]   [Full Text] [Related]  

  • 6. The treatment of schizophrenic psychoses with gamma-type endorphins.
    van Praag HM; Verhoeven WM; van Ree JM; de Wied D
    Biol Psychiatry; 1982 Jan; 17(1):83-98. PubMed ID: 6174158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuroendocrine factors in pathogenesis of motion sickness and the protective effect of drugs].
    Shashkov AV; Karsanova SK; Iasnetsov VV; Tigranian RA; Shashkov VS
    Eksp Klin Farmakol; 2004; 67(2):3-7. PubMed ID: 15188750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Endorphins and schizophrenias. II. Trial treatment of schizophrenia with des-Tyr-gamma-endorphin (DT gamma E) (including a personal trial)].
    Bourgeois M; Laforge E; Muyard J; Blayac J; Lemoine J
    Ann Med Psychol (Paris); 1980 Nov; 138(9):1112-9. PubMed ID: 6111283
    [No Abstract]   [Full Text] [Related]  

  • 9. [Participation of endogenous opioid peptides in the pathogenesis of motion sickness].
    Iasnetsov VV; Vakulina OP; Sabaev VV; Mokrousova AV; Karsanova SK
    Biull Eksp Biol Med; 1985 Aug; 100(8):164-7. PubMed ID: 3161557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vestibuloprotective activity of serum proteins from seal's blood].
    Iasnetsov VV; Gromov AN; Kiseleva NM; Rusakov DIu; Batrakov SG; Evstratov AV; Shashkov VS
    Biull Eksp Biol Med; 1994 Apr; 117(4):444-5. PubMed ID: 9296683
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of schizophrenic psychoses with gamma-type endorphins].
    van Praag HM; Verhoeven WM; van Ree JM; de Wied D
    Ned Tijdschr Geneeskd; 1981 Nov; 125(48):1963-9. PubMed ID: 6171738
    [No Abstract]   [Full Text] [Related]  

  • 12. [The adequacy of a new method for assessing the vestibular protective effect of biologically active substances].
    Karkishchenko NN; Dimitriadi NA
    Farmakol Toksikol; 1991; 54(5):14-6. PubMed ID: 1800137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effect of gamma-endorphin-type peptides in anaphylactic shock.
    Amir S; van Ree JM
    Brain Res; 1985 Mar; 329(1-2):329-33. PubMed ID: 2579712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prospects for the application and basic research on small regulatory peptides].
    Ashmarin IP
    Vopr Med Khim; 1984; 30(3):2-7. PubMed ID: 6206647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-Endorphin, gamma-endorphin, and their des-tyrosine fragments: distribution in rat brain.
    Verhoef J; Wiegant VM; De Wied D
    Adv Biochem Psychopharmacol; 1982; 33():69-74. PubMed ID: 6181665
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of the synthetic peptides gamma-type endorphins in mentally ill patients.
    van Ree JM; Verhoeven WM; de Wied D; van Praag HM
    Ann N Y Acad Sci; 1982; 398():478-95. PubMed ID: 6186176
    [No Abstract]   [Full Text] [Related]  

  • 17. [Neuropharmacology of the autonomic vestibular syndrome].
    Shashkov VS; Iasnetsov VV; Drozd IuV; Karsanova SK; Tigranian RA
    Farmakol Toksikol; 1988; 51(2):30-6. PubMed ID: 2897933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Endorphins of the gamma type in the treatment of schizophrenic psychoses].
    Verhoeven WM; Van Ree JM
    Acta Psychiatr Belg; 1984; 84(2):160-72. PubMed ID: 6204507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Model of motion sickness in white mice experiments].
    Zhabko EP; Lukomskaia NIa
    Aviakosm Ekolog Med; 1997; 31(6):66-8. PubMed ID: 9483286
    [No Abstract]   [Full Text] [Related]  

  • 20. Naloxone enhances motion sickness: endorphins implicated.
    Allen ME; McKay C; Eaves DM; Hamilton D
    Aviat Space Environ Med; 1986 Jul; 57(7):647-53. PubMed ID: 3741286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.